Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-09

FDA Approved: ISOTRETINOIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for isotretinoin submitted by Zydus Pharmaceuticals USA Inc. (ANDA 211568).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

SUPPL AP for ISOTRETINOIN (ISOTRETINOIN)